News Releases

Select year
Categories

Myriad Genetics Acquires Novel Therapeutic Drug Management Technology From Saladax Biomedical

Oct 07, 2008 | Pipeline

Read more

Myriad Genetics Announces Topline Results of Phase 1 Trial of Vivecon for HIV

Sep 17, 2008 | Pipeline

Read more

Myriad Genetics' Alzheimer's Disease Drug Mechanism of Action Detailed in Nature Article

Jun 11, 2008 | Pipeline

Read more

Myriad Genetics Announces Completion of Phase 1 Trial of Anti-Thrombin Drug MPC-0920

Jan 29, 2008 | Pipeline

Read more